Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease
Metabolic syndrome (MetS) is a clinical syndrome that consists of visceral obesity, dyslipidemia, hypertension, and impaired insulin sensitivity. Although individual components of MetS have been implicated in the development of chronic kidney disease (CKD), few studies have examined the effect of co...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.4061/2011/963517 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546123696308224 |
|---|---|
| author | Kosaku Nitta |
| author_facet | Kosaku Nitta |
| author_sort | Kosaku Nitta |
| collection | DOAJ |
| description | Metabolic syndrome (MetS) is a clinical syndrome that consists of visceral obesity, dyslipidemia, hypertension, and impaired insulin sensitivity. Although individual components of MetS have been implicated in the development of chronic kidney disease (CKD), few studies have examined the effect of combinations of the components of MetS on the development of CKD and cardiovascular disease (CVD). The prevalence of MetS is increasing worldwide in both developing and developed countries, and early detection and treatment of MetS would be a cost-effective strategy for preventing the development of CKD. Visceral obesity and insulin resistance are two important features of MetS that may be associated with renal damage. Lifestyle modifications, including caloric restriction and exercise, are necessary to treat MetS. Initial antihypertensive therapy should consist of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker. An improved understanding of the mechanism responsible for the association between MetS and renal damage should be helpful in determining the treatment regimens directed at cardiovascular and renal protection. |
| format | Article |
| id | doaj-art-3c141a2d77664490a90621deb6dbf409 |
| institution | Kabale University |
| issn | 2090-0597 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiology Research and Practice |
| spelling | doaj-art-3c141a2d77664490a90621deb6dbf4092025-02-03T07:23:52ZengWileyCardiology Research and Practice2090-05972011-01-01201110.4061/2011/963517963517Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular DiseaseKosaku Nitta0Department of Medicine, Kidney Center, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, JapanMetabolic syndrome (MetS) is a clinical syndrome that consists of visceral obesity, dyslipidemia, hypertension, and impaired insulin sensitivity. Although individual components of MetS have been implicated in the development of chronic kidney disease (CKD), few studies have examined the effect of combinations of the components of MetS on the development of CKD and cardiovascular disease (CVD). The prevalence of MetS is increasing worldwide in both developing and developed countries, and early detection and treatment of MetS would be a cost-effective strategy for preventing the development of CKD. Visceral obesity and insulin resistance are two important features of MetS that may be associated with renal damage. Lifestyle modifications, including caloric restriction and exercise, are necessary to treat MetS. Initial antihypertensive therapy should consist of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker. An improved understanding of the mechanism responsible for the association between MetS and renal damage should be helpful in determining the treatment regimens directed at cardiovascular and renal protection.http://dx.doi.org/10.4061/2011/963517 |
| spellingShingle | Kosaku Nitta Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease Cardiology Research and Practice |
| title | Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease |
| title_full | Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease |
| title_fullStr | Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease |
| title_full_unstemmed | Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease |
| title_short | Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease |
| title_sort | possible link between metabolic syndrome and chronic kidney disease in the development of cardiovascular disease |
| url | http://dx.doi.org/10.4061/2011/963517 |
| work_keys_str_mv | AT kosakunitta possiblelinkbetweenmetabolicsyndromeandchronickidneydiseaseinthedevelopmentofcardiovasculardisease |